| Identification | Back Directory | [Name]
PKCη pseudosubstrate inhibitor,myristoylated | [CAS]
908012-19-1 | [Synonyms]
PKCη pseudosubstrate inhibitor,myristoylated | [Molecular Formula]
C101H185N41O23S | [MOL File]
908012-19-1.mol | [Molecular Weight]
2373.88 |
| Chemical Properties | Back Directory | [density ]
1.460±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | [storage temp. ]
-20°C | [form ]
lyophilized solid | [color ]
White to off-white | [Water Solubility ]
water: 2mg/mL | [Sequence]
{Myr}-Thr-Arg-Lys-Arg-Gln-Arg-Ala-Met-Arg-Arg-Arg-Val-His-Gln-Ile-Asn-Gly |
| Hazard Information | Back Directory | [Uses]
PKCη pseudosubstrate inhibitor,myristoylated is cell permeable and can be used to study the mechanism of action of PKCη[1]. | [Biological Activity]
Cell permeable: yes''Primary Target
protein kinase Cθ''Product competes with ATP.''Reversible: yes | [References]
[1] Muzorewa TT, et al. Coordinated regulation of endothelial calcium signaling and shear stress-induced nitric oxide production by PKCβ and PKCη. Cell Signal. 2021 Nov;87:110125. DOI:10.1016/j.cellsig.2021.110125 |
|
|